Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Avasopasem manganese (GC4419) protects against cisplatin-induced chronic kidney disease: An exploratory analysis of renal metrics from a randomized phase 2b clinical trial in head and neck cancer patients.
Mapuskar KA, Vasquez Martinez G, Pulliam CF, Petronek MS, Steinbach EJ, Monga V, Furqan M, Jetton JG, Saunders DP, Pearce A, Davidson S, Pitre L, Dunlap NE, Fairbanks R, Lee CM, Mott SL, Bodeker KL, Cl H, Buatti JM, Anderson CM, Beardsley RA, Holmlund JT, Zepeda-Orozco D, Spitz DR, Allen BG. Mapuskar KA, et al. Among authors: furqan m. Redox Biol. 2023 Apr;60:102599. doi: 10.1016/j.redox.2022.102599. Epub 2023 Jan 3. Redox Biol. 2023. PMID: 36640725 Free PMC article. Clinical Trial.
SBRT to adrenal metastases provides high local control with minimal toxicity.
Plichta K, Camden N, Furqan M, Hejleh TA, Clamon GH, Zhang J, Flynn RT, Bhatia SK, Smith MC, Buatti JM, Allen BG. Plichta K, et al. Among authors: furqan m. Adv Radiat Oncol. 2017 Aug 4;2(4):581-587. doi: 10.1016/j.adro.2017.07.011. eCollection 2017 Oct-Dec. Adv Radiat Oncol. 2017. PMID: 29204525 Free PMC article.
Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors.
Park H, Shapiro GI, Gao X, Mahipal A, Starr J, Furqan M, Singh P, Ahrorov A, Gandhi L, Ghosh A, Hickman D, Gallacher PD, Wennborg A, Attar EC, Awad MM, Das S, Dumbrava EE. Park H, et al. Among authors: furqan m. ESMO Open. 2022 Oct;7(5):100573. doi: 10.1016/j.esmoop.2022.100573. Epub 2022 Sep 7. ESMO Open. 2022. PMID: 36084396 Free PMC article. Clinical Trial.
Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages.
Mandula JK, Sierra-Mondragon RA, Jimenez RV, Chang D, Mohamed E, Chang S, Vazquez-Martinez JA, Cao Y, Anadon CM, Lee SB, Das S, Rocha-Munguba L, Pham VM, Li R, Tarhini AA, Furqan M, Dalton W, Churchman M, Moran-Segura CM, Nguyen J, Perez B, Kojetin DJ, Obermayer A, Yu X, Chen A, Shaw TI, Conejo-Garcia JR, Rodriguez PC. Mandula JK, et al. Among authors: furqan m. Immunity. 2024 Apr 11:S1074-7613(24)00141-9. doi: 10.1016/j.immuni.2024.03.020. Online ahead of print. Immunity. 2024. PMID: 38636522
The current state of neurosurgical care in Africa - a correspondence.
Oduoye MO, Riaz R, Khan A, Okon II, Akpan U, Bello IM, Munsab R, Furqan M, Akilimali A. Oduoye MO, et al. Among authors: furqan m. Neurosurg Rev. 2024 Apr 11;47(1):149. doi: 10.1007/s10143-024-02398-w. Neurosurg Rev. 2024. PMID: 38600422 No abstract available.
Barriers to accessing neurosurgical care in low- and middle-income countries from Africa: editorial.
Okon II, Akilimali A, Furqan M, Precious FK, Gbayisomore TJ, Atallah O, Erhayanmen MO, Christopher EC, Umutoni F, Nkeshimana M, Lucero-Prisno DE 3rd. Okon II, et al. Among authors: furqan m. Ann Med Surg (Lond). 2024 Jan 25;86(3):1247-1248. doi: 10.1097/MS9.0000000000001758. eCollection 2024 Mar. Ann Med Surg (Lond). 2024. PMID: 38463130 Free PMC article. No abstract available.
118 results